Showing results (331-340 of 434) with videos related to
Sort By:
Pageof 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2012
Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinibElizabeth A Punnoose, Siminder Atwal, Weiqun Liu, et al.Journal of Medicinal Chemistry|August 14, 2020
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate CancerAsif Noor, Jessica K Van Zuylekom, Stacey E Rudd, et al.EJNMMI Physics|June 1, 2017
EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization programCharline Lasnon, Elske Quak, Pierre-Yves Le Roux, et al.Insights Into Imaging|October 25, 2012
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Fergus Davnall, Connie S P Yip, Gunnar Ljungqvist, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 15, 2023
Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patientsMichelle Tew, Abby P Douglas, Jeff Szer, et al.Frontiers in Medicine|March 5, 2021
Gallium-68 Ventilation/Perfusion PET-CT and CT Pulmonary Angiography for Pulmonary Embolism Diagnosis: An Interobserver Agreement StudyRomain Le Pennec, Amir Iravani, Beverley Woon, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2017
Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of 68Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate CancerMichael S Hofman, Peter Eu, Price Jackson, et al.Clinical & Translational Immunology|November 8, 2021
Intratumoral T-cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B-cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R-CHOP) chemoimmunotherapyMohamed Shanavas, Soi-Cheng Law, Mark Hertzberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2012
Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancerQuynh-Thu Le, Richard Fisher, Kelly S Oliner, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2010
¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancerAshley M Groves, Manu Shastry, Manuel Rodriguez-Justo, et al.Pageof 44